Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 17881 - 17900 out of 554124 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FX07) blinatumomab (adm: P) | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab (adm: P) | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX08) elotuzumab (adm: P) | Empliciti 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FX08) elotuzumab (adm: P) | Empliciti 400 mg powder for injection, 1 vial | Powder for injection 400 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FX09) mogamulizumab | Poteligeo 20 mg/5 mL injection, 5 mL vial | Solution concentrate for I.V. infusion 20 mg in 5 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Sezary Syndrome;Mycosis Fungoides | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (L01FX09) mogamulizumab | Poteligeo 20 mg/5 mL injection, 5 mL vial | Solution concentrate for I.V. infusion 20 mg in 5 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Sezary Syndrome;Mycosis Fungoides | KYOWAKIRINAUSTRALIAPTYLTD |
| Australia | (L01FX13) enfortumab vedotin | Padcev 20 mg powder for injection, 1 vial | Powder for I.V. infusion 20 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | AstellasPharmaAustraliaPtyLtd |
| Australia | (L01FX13) enfortumab vedotin | Padcev 30 mg powder for injection, 1 vial | Powder for I.V. infusion 30 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | AstellasPharmaAustraliaPtyLtd |
| Australia | (L01FX17) sacituzumab govitecan | Trodelvy 180 mg powder for injection, 1 vial | Powder for injection 180 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciencesPtyLimited |
| Australia | (L01FX17) sacituzumab govitecan | Trodelvy 180 mg powder for injection, 1 vial | Powder for injection 180 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciencesPtyLimited |
| Australia | (L01FX18) amivantamab | Rybrevant 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Janssen-CilagPtyLtd |
| Australia | (L01FX18) amivantamab | Rybrevant 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Janssen-CilagPtyLtd |
| Australia | (L01FX20) tremelimumab | Imjudo 300 mg/15 mL injection, 15 mL vial | Solution concentrate for I.V. infusion 300 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FX28) glofitamab | Columvi 10 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 10 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | RocheProductsPtyLtd |
| Australia | (L01FX28) glofitamab | Columvi 10 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 10 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | RocheProductsPtyLtd |
| Australia | (L01FX28) glofitamab | Columvi 2.5 mg/2.5 mL injection, 2.5 mL vial | Solution concentrate for I.V. infusion 2.5 mg in 2.5 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | RocheProductsPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01XA01) cisplatin | Cisplatin (Accord) 100 mg/100 mL injection, 100 mL vial | I.V. injection 100 mg in 100 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcarePty.Ltd. |
| Australia | (L01XA01) cisplatin | Cisplatin (Accord) 50 mg/50 mL injection, 50 mL vial | I.V. injection 50 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcarePty.Ltd. |
Pages
